Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
OCUL
OCULAR THERAPEUTIX, INC
NASDAQ · Pharmaceutical Preparations
Last close
$7.67
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$1.68B
RECENT INSIDER TRADES
2026-10-06
· Heier Jeffrey S.
(Chief Scientific Officer)
· SELL
2026-10-06
· Kaiser Peter
(Chief Development Officer)
· SELL
2026-09-02
· Notman Donald
(Chief Operating Officer)
· SELL
2026-08-26
· Dugel Pravin
(See Remarks)
· SELL
2026-08-26
· Heier Jeffrey S.
(Chief Scientific Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
285
Shares held
232,408,698
Value
$2.19B
Percent of shares outstanding
105.83%
As of quarter end
2026-06-30
RECENT NEWS
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix presents at Euretina 2026
Ocular Therapeutix CDO Peter Kaiser sells $70,429 in stock
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS